Description of Medical ServicePercutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/transeptal techniques is performed while the heart is beating, which better allows the identification of the origin of mitral regurgitation (MR).
Description of Medical ConditionMR occurs when the leaflets (or flaps) of the heart’s mitral value do not close properly and leak. The mitral valve is a one-way valve that separates the left atrium (a chamber in the heart which collects blood from the lungs) from the left ventricle (a chamber in the heart which pumps blood to the rest of the body). During pumping, the leak in the mitral valve causes blood to flow backwards (MR) into the left atrium, thereby decreasing blood flow to the body. To maintain blood flow to the body and compensate for the MR, the left ventricle must pump harder. Back flow due to MR places an extra burden on the left ventricle and lungs. Eventually, this burden can cause other problems such as: stroke, sudden death, irregular heartbeat, increasing damage to the heart muscle (progressive myocardial injury); inability to maintain adequate circulation of blood (congestive heart failure).
Reason for ApplicationNew MBS item
Medical Service TypeTherapeutic
Previous Application NumberNot Applicable
PICO ConfirmationDate of released for comment 27 January 2012
Consultation Decision Analytic Protocol (DAP) (PDF 566 KB)
Consultation Decision Analytic Protocol (DAP) (Word 794 KB)
Date closed for comments 10 March 2012
12 – 13 April 2012
Final Decision Analytic Protocol (DAP) (PDF 779 KB)
Final Decision Analytic Protocol (DAP) (Word 2048 KB)
Public Summary DocumentPublic Summary Document (PDF 836 KB)
Public Summary Document (Word 248 KB)